Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs

– Company will host virtual R&D event in early January 2023, timed to coincide with the 41st Annual JP Morgan Healthcare Conference, to showcase complete...

Related Keywords

Minnesota ,United States ,Mayo Clinic In Rochester ,American ,Harry Thomasian Jr ,Stevenm Harasym ,Helen Sabzevari ,Clintt Allen ,National Cancer Institute ,Surgical Oncology Program ,Drug Administration ,Nasdaq ,Exchange Commission ,Cancer Research ,American Society Of Hematology ,Key Program ,Precigen Inc ,Healthcare Conference ,American Society ,Annual Meeting ,Trans Ova ,Senior Investigator ,Safety Study ,Positive Acute Myeloid Leukemia ,Higher Risk Myelodysplastic Syndromes ,Mayo Clinic ,Dose Level ,Dose Expansion Study ,Advanced Hematologic ,Solid Tumor Malignancies ,First Nine Months ,Results Compared ,Prior Year ,Advancing Medicine ,Annual Report ,Precigen ,Nc ,